LactoSpore® is a lactic acid producing Bacillus preparation manufactured and distributed by the SABINSA CORPORATION. This section reviews the background, nutritional and therapeutic aspects and current status of the use of lactic acid producing bacillus preparations, and presents arguments for the superiority of LactoSpore® over other such products in the market, known as "probiotics", used in microbiotherapy.
The foundations of probiotic (meaning "in favor of life") microbiotherapy lie in the postulate of Metchnikoff, a Russian physician, that the growth of toxin-producing putrefactive organisms in the gastrointestinal tract could be controlled by the implantation of beneficial lactobacilli in the gut. The clinical application of preparations containing lactobacilli was initiated on the basis of Metchnikoff's THEORY OF LONGEVITY, which associates with prolonged youthfulness and a healthy old age with the continuous ingestion of lactobacilli. Metchnikoff attributed the longevity of the residents of the Balkan countries to the regular consumption of Bulgarian buttermilk 1. In the early 1900's, he claimed to have successfully cured many of his patients who suffered from a wide variety of organic illnesses, ranging from dryness of skin and gastrointestinal disorders to atherosclerosis, through the therapeutic use of Lactobacilli.